Lazard Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Buy |
|
|||||
|
2025
Q1 | $737K | Buy |
|
|||||
|
2024
Q4 | $104K | Sell |
|
|||||
|
2024
Q3 | $93K | Buy |
|
|||||
|
2024
Q2 | $58K | Sell |
|
|||||
|
2024
Q1 | $75K | Sell |
|
|||||
|
2023
Q4 | $346K | Buy |
|
|||||
|
2023
Q3 | $327K | Buy |
|
|||||
|
2023
Q2 | $132K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $62K | Hold |
|
|||||
|
2022
Q3 | $59K | Sell |
|
|||||
|
2022
Q2 | $101K | Buy |
|
|||||
|
2022
Q1 | $65K | Buy |
|
|||||
|
2021
Q4 | $59K | Buy |
|
|||||
|
2021
Q3 | $46K | Sell |
|
|||||
|
2021
Q2 | $59K | Hold |
|
|||||
|
2021
Q1 | $50K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $51K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $54K | Buy |
|
|||||
|
2019
Q3 | $12K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $2.01M | Hold |
|
|||||
|
2018
Q1 | $1.54M | Sell |
|
|||||
|
2017
Q4 | $1.4M | Sell |
|
|||||
|
2017
Q3 | $2.15M | Sell |
|
|||||
|
2017
Q2 | $2.75M | Sell |
|
|||||
|
2017
Q1 | $2.07M | Sell |
|
|||||
|
2016
Q4 | $3.62M | Hold |
|
|||||
|
2016
Q3 | $3.54M | Hold |
|
|||||
|
2016
Q2 | $2.92M | Buy |
|